Difficult transition from a new oral anticoagulant to parenteral anticoagulant in an overweight female

E-ISSN： 1751-553x|37|5|e135-e136

ISSN： 1751-5521

Source： International Journal Of Laboratory Hematology, Vol.37, Iss.5, 2015-10, pp. : e135-e136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A cost study of new media supported near oral anticoagulant treatment follow-up

By Niiranen S. Lamminen H. Niemi K. Mattila H. Kalli S.

International Journal of Medical Informatics, Vol. 70, Iss. 1, 2003-04 ,pp. : 19-29

Elsevier

Access to resources Recommend Favorite

Evaluating the efficacy and safety of apixaban, a new oral anticoagulant, using Bayesian meta-analysis

By Villa Lorenzo Malone Daniel Ross Daniel

International Journal of Hematology, Vol. 98, Iss. 4, 2013-10 ,pp. : 390-397

Springer Publishing Company

Access to resources Recommend Favorite

Intravascular Targeting of a New Anticoagulant Heparin Compound

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 9, Iss. 2, 2009-06 ,pp. : 149-158

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Anticoagulant Treatment in Very Elderly Patients with Atrial Fibrillation

By Pengo V.

Comprehensive Therapy, Vol. 27, Iss. 1, 2001-03 ,pp. : 7-10

Humana Press, Inc

Access to resources Recommend Favorite

Is There a Role for Oral Anticoagulant Therapy in Patients with Peripheral Arterial Disease?

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 269-273

Bentham Science Publishers

Access to resources Recommend Favorite